NCT07480356
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07480356
Title Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer (ADVANCED-3)
Acronym ADVANCED-3
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Protara Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.